![Ivor MacLeod](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ivor MacLeod
Financieel Directeur/CFO bij
SCYNEXIS, INC.
Vermogen: 42 556 $ op 31-05-2026
Profiel
Ivor MacLeod is currently Chief Financial Officer at SCYNEXIS, Inc. since 2022.
Formerly, Mr. MacLeod was Chief Financial & Accounting Officer at Athersys, Inc. from 2021 to 2022, Chief Financial & Compliance Officer, SVP at Eisai, Inc. from 2015 to 2018, Vice President-Finance at Merck & Co., Inc. from 2012 to 2015, and Vice President-Finance & Information Technology at Hoffmann-La Roche, Inc. Education includes undergraduate studies at the University of St. Andrews.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SCYNEXIS, INC. 0,08% | 01-04-2026 | 60.363 ( 0,08% ) | 42 556 $ | 31-05-2026 |
Actieve functies van Ivor MacLeod
| Bedrijven | Functie | Begin |
|---|---|---|
| SCYNEXIS, INC. | Financieel Directeur/CFO | 24-10-2022 |
Eerdere bekende functies van Ivor MacLeod
| Bedrijven | Functie | Einde |
|---|---|---|
| ATHERSYS, INC. | Financieel Directeur/CFO | 30-06-2022 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Financieel Directeur/CFO | 01-01-2018 |
| MERCK & CO., INC. | Financieel Directeur/CFO | 01-01-2015 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Financieel Directeur/CFO | - |
Opleiding van Ivor MacLeod
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
54
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
University of St. Andrews
 University of St. Andrews Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Athersys, Inc.
 Athersys, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops novel and proprietary therapies | Health Technology |
Eller College of Management
 Eller College of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
